排序方式: 共有753条查询结果,搜索用时 0 毫秒
111.
A case of uremia resulting from bilateral Hodgkin's lymphomatous infiltration of kidneys is reported. Uremia was an initial feature in the case and was the eventual cause of death. 相似文献
112.
113.
Serum samples of 403 asymptomatic blood donors carrying hepatitis B surface antigen (HB5Ag) were concentrated threefold and tested for e antigen and antibody to e antigen (anti-e) by immunodiffusion. Hepatitis B antigen (HBAg)-associated deoxyribonucleic acid (DNA) polymerase activity was specifically determined by the difference in incorporation of [methyl-3H]thymidine 5' -triphosphate into DNA by an aliquot of centrifuged serum samples after it had been treated either with normal rabbit serum or with rabbit antibody to HBSAg. All of 58 serum samples containing e antigen revealed HBAg-associated DNA polymerase activity, whereas none of 96 samples containing anti-e did. In the remaining 249 samples in which neither e antigen nor anti-e was found, 62 showed specific DNA polymerase activity, although at lower levels than the samples containing e antigen. 相似文献
114.
The authors propose a method of phalloplasty with a full-thickness flap on the vasculo-nervous pedicle taken from the femur. The method of raising such a flap and the technique of its displacement to the area of the pubic articulation if described. This method of phalloplasty was used in 10 patients aged 19-36 years. In all of them full taking of the transplant was noted. Good cosmetic and functional results were obtained. 相似文献
115.
SJ Freedman DF Geesaman R Gilman MC Green RJ Holt HE Jackson ER Kinney R Kowalczyk C Marchand J Napolitano J Nelson DH Potterveld B Zeidman RE Segel T Tung D Beck G Boyd D Collins BW Filippone CE Jones J Jourdan RD McKeown R Milner R Walker PE Bosted Z Meziani R Minehart 《Canadian Metallurgical Quarterly》1993,48(4):1864-1878
116.
117.
Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma
JC Buckner PA Burch TL Cascino JR O''Fallon BW Scheithauer 《Canadian Metallurgical Quarterly》1998,36(1):65-70
The aim of this study was to investigate the influence of interferon-alpha (IFN-alpha) on bone marrow fibrosis associated with chronic myelogenous leukemia (CML). Eighty-two bone marrow biopsies from 41 patients in chronic phase CML were stained with Snook's reticulin stain for argyrophilic fibers. Grading of reticulin fibrosis (scale of 1 to 4) was according to the quantity and pattern of distribution of reticulin. The interval between biopsies was a median of 25 months (range 12 to 40 months). Patients had been treated with IFN-alpha for at least 12 months, were still on IFN-alpha therapy during the study, and had achieved at least a complete hematological response. Before the start of IFN-alpha therapy, reticulin fibrosis was grade 1-2 in 23 patients (56%) and grade 3-4 in 18 (44%). During IFN-alpha therapy, reticulin fibrosis in bone marrow did not worsen or was reduced in 33 patients (80%) and increased by one grade in eight patients (20%). Only five patients (12%) with limited fibrosis (grade 1-2) before start of IFN-alpha therapy showed an increase towards significant fibrosis (grade 3-4), while eight of the 18 patients (44%) with grade 3-4 fibrosis achieved a decrease of fiber content in bone marrow. In summary, IFN-alpha was not associated with an enhancing effect on myelofibrosis in patients with CML and may have prevented increasing fibrosis in patients who respond to therapy. 相似文献
118.
119.
120.